Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Senores Pharmaceuticals IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Senores Pharmaceuticals IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE
The Company Key Performance Indicates the pre-issue EPS of ₹12.21 and post-issue EPS of ₹7.10 for FY24. The pre-issue P/E ratio is 32.02x, while the post-issue P/E ratio is 55.05x against the Industry P/E ratio is 39x. The company's ROCE for FY24 is 11.73%, ROE for FY24 is 23.60% and RoNW 23.60%. The Annualised EPS based on the latest financial data is ₹14.4 and PE ratio is 27.15x. These metrics suggest that the IPO is fairly priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | ₹12.21 |
| EPS Post IPO (Rs.) | ₹7.10 |
| Adjusted 12M EPS Post IPO (Rs.) | |
| P/E Pre IPO | 32.02 |
| P/E Post IPO | 55.05 |
| Adjusted 12M P/E Post IPO | |
| ROE | 23.60% |
| ROCE | 11.73% |
| P/BV | 2.27 |
| Debt/Equity | 1.07 |
| RoNW | 23.60% |
| EBITDA Margin | |
| PAT Margin |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
